OncoZenge AB (publ) (“OncoZenge” or the “Company”) announces that the Company has entered into a binding agreement to partner with L. Molteni & C. dei F.lli Alitti, Società di Esercizio S.p.A ...

Santhera Pharmaceuticals (SIX: SANN) announces that at its Capital Markets Day (CMD) in Zurich today, the Company will discuss the commercial progress with the global roll-out of AGAMREE® for the ...

The signing ceremony was attended by a distinguished group of senior executives from both companies. The agreement was signed on behalf of United Pharmacies by Dr. Shalaei Taha, Chief Commercial ...

What kind of commercial vehicle do you need? There are many types, and each serves a different purpose. Some carry heavy ...

Several ASX healthcare companies are leading the charge in finding new treatments for complex neurological disorders.

The growing burden of misinformation is a complex issue that demands a direct-to-patient channel through trusted sources. By ...

Swiss National Bank decreased its holdings in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 9.9% during the 4th quarter, according to its most recent disclosure with the ...

The NSE Nifty 50 on Tuesday rose 0.04% to 23,668.65 after crossing 23,800 intraday, while the BSE Sensex ended 0.04% higher.

“We are excited to collaborate with Scienture to enhance its commercial effectiveness,” said Paul Mignon, President, Deployment Solutions, Syneos Health. “Our team is committed to delivering tailored ...

Gilead Sciences sees strong growth in HIV & oncology with BIKTARVY & TRODELVY. Learn about upcoming drugs & market potential ...

Commercially reasonable efforts (CRE) provisions are a common feature in technology and life sciences agreements, particularly in ...